Andrea Electronics Corporation designs, develops, and manufactures microphone technologies and products for speech-based applications software and communications. The company’s digital signal processing microphone and audio software products include the use of various technologies, such as Digital Super Directional Array microphone technology that enables far-field communications by centering microphone sensitivity on a user’s voice and canceling noise outside of that signal; PureAudio, a noise canceling algorithm; EchoStop, an acoustic echo canceller for use with conferencing systems and cellular car phone kits; SuperBeam, a digital algorithm that forms an acoustic beam, which extends from the microphone to the speech source in an environment; and Direction Finding and Tracking Array that detects the presence of a user’s voice. Its products include Superbeam Array Microphone, AudioCommander, AutoArray Microphone, and VoiceCenter. Andrea’s anti-noise products comprise Noise Cancellation (NC) Microphone Technology that reduces the transmission of noise from the speaker’s location; Active Noise Cancellation (ANC) Microphone Technology that electronically cancels the transmission of noise from the speaker’s location; and Active Noise Reduction (ANR) Earphone Technology, which electronically reduces the amount of noise. Its anti-noise products include a line of headsets, handsets, and related accessories that incorporate the NC, ANC, and ANR technologies. The company’s products are used primarily in personal computing, audio and video conferencing, and in-vehicle communications markets. Andrea Electronics markets and sells its products directly to end users through its Website and computer product distributors, as well as through value-added resellers to original equipment manufacturers and software publishers worldwide.
Millennium Biotechnologies Group, Inc., through its subsidiary, Millennium Biotechnologies, Inc., operates as a research-based bio-nutraceutical company. The company engages in the research, development, and marketing of nutritional supplements, which comprise RESURGEX, RESURGEX Select, and RESURGEX Plus, which are multi-component nutritional formulas designed to address the multiple nutritional needs (oxidative stress, lean tissue loss, energy depletion, immune support, and weight loss) of immuno-compromised conditions as an adjunct to medical treatment. Its products are used by immuno-compromised individuals undergoing medical treatment for diseases, including cancer, as well as individuals living with human immunodeficiency virus/acquired immune deficiency syndrome, wound healing and post-surgical healing, and geriatric.
